<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01974076</url>
  </required_header>
  <id_info>
    <org_study_id>HC13276</org_study_id>
    <nct_id>NCT01974076</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation (tDCS) as an Adjunct to Cognitive Behaviour Therapy (CBT)</brief_title>
  <official_title>A Study of Transcranial Direct Current Stimulation (tDCS) as an Adjunct to Cognitive Behavioural Therapy (CBT) for Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of New South Wales</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Belmont Private Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of New South Wales</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate whether transcranial direct current stimulation (tDCS) can
      enhance the efficacy of cognitive behavioural therapy for the treatment of depression.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Montgomery Asberg Depression Rating Scale for Depression (MADRS)</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depression and Anxiety Stress Scale</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Active tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active tDCS + CBT</intervention_name>
    <arm_group_label>Active tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham tDCS + CBT</intervention_name>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Participants will be ≥ 18 years old.

          2. Have a DSM-IV diagnosis of Major Depressive Episode of minimum 4 weeks duration.

          3. MADRS score ≥ 20 at study entry.

        Exclusion Criteria:

          1. Participant is unable to give informed consent.

          2. DSM-IV diagnosis of psychotic disorder (lifetime).

          3. Bipolar disorder diagnosis and not on a mood stabiliser.

          4. Eating disorder (current or within past year).

          5. Obsessive compulsive disorder (lifetime).

          6. Post-traumatic stress disorder (current or within past year).

          7. Mental retardation.

          8. Drug or alcohol abuse or dependence (preceding 3 months).

          9. Inadequate response to ECT (current episode of depression).

         10. Rapid clinical response required, e.g., high suicide risk, inanition or psychosis.

         11. Clinically defined neurological disorder or insult.

         12. Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash)
             at proposed electrode sites.

         13. Pregnancy.

         14. Concurrent long acting benzodiazepines, ritalin or dexamphetamine medication.

         15. Change in psychotropic medication during 2-week period prior to the study or during
             the course of the 3-week trial.

         16. Participant becomes hypomanic or manic, as defined by DSM-IV.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sandy Sacre</last_name>
    <email>sandy.sacre@healthecare.com.au</email>
  </overall_contact>
  <location>
    <facility>
      <name>Belmont Private Hospital</name>
      <address>
        <city>Carina, Brisbane</city>
        <state>Queensland</state>
        <zip>4152</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Sacre</last_name>
      <email>sandy.sacre@healthecare.com.au</email>
    </contact>
    <investigator>
      <last_name>Sandy Sacre</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Saibal Guha</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2013</study_first_submitted>
  <study_first_submitted_qc>October 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2013</study_first_posted>
  <last_update_submitted>December 2, 2014</last_update_submitted>
  <last_update_submitted_qc>December 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of New South Wales</investigator_affiliation>
    <investigator_full_name>Colleen Loo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

